International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Luciano J. Costa, Benjamin A. Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C. Ye, Gordon Cook, Robert F. Cornell, Sarah A. Holstein, Qian Shi, James Omel, Natalie S. Callander, Wee Joo Chng, Vânia Hungria, Ângelo Maiolino, Edward A. Stadtmauer, Sergio Giralt, Marcelo C. Pasquini, Andrzej Jakubowiak, Gareth J. Morgan, Amrita Krishnan, Graham Jackson, Mohamad Mohty, María‐Victoria Mateos, Meletious A. Dimopoulos, Thierry Façon, Andrew Spencer, Jesús F. San Miguel, Parameswaran Hari, Saad Z. Usmani, Salomon Manier, Phillip McCarthy, Shaji Kumar, Francesca Gay, Bruno Paiva
Topics & Concepts
Clinical trialMedicineMinimal residual diseaseMultiple myelomaMedical physicsHarmonizationClinical endpointOncologyIntensive care medicineInternal medicineBone marrowPhysicsAcousticsMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer therapeutics and mechanisms